计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| R337615-5mg |
5mg |
现货 ![]() |
| |
| R337615-25mg |
25mg |
现货 ![]() |
| |
| R337615-50mg |
50mg |
现货 ![]() |
|
| 英文别名 | (R)-1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexan-1-ol | 1-[(1R)-2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol | (R)-Venlafaxine | R-Venlafaxine | 1-[(1R)-2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol |
|---|---|
| 规格或纯度 | ≥95% |
| 英文名称 | R-Venlafaxine |
| 储存温度 | 2-8°C储存 |
| 运输条件 | 冰袋运输 |
| 产品介绍 |
R-文拉法辛是文拉法辛的光学活性形式。文拉法辛是苯乙胺的衍生物,据报道可通过阻止神经胺如5-羟色胺(5-羟色胺; 5-HT)和去甲肾上腺素(去甲肾上腺素)的突触前再摄取来促进中枢神经系统内的神经传递。还报道了Velanfaxine是多巴胺再摄取的弱抑制剂。|体外研究表明,Venlafaxine对毒蕈碱,组胺能或α-1肾上腺素受体没有明显的活性。据报道,文拉法辛的代谢是通过细胞色素P450(CYP)酶CYP2D6发生的,产生O-去甲基文拉法辛。CYP3A4产生较少的代谢产物N-去甲基文拉法辛。 R-Venlafaxine is an optically active version of Venlafaxine . Venlafaxine is a derivative of phenylethylamine which is reported to facilitate neurotransmission within the central nervous system via blocking the presynaptic reuptake of neuroamines such as serotonin (5-hydroxytryptamine; 5-HT) and noradrenaline (norepinephrine). Velanfaxine is also reported to be a weak inhibitor of dopamine reuptake.|In vitro|studies indicate that Venlafaxine does not demonstrate significant activity for muscarinic, histaminergic or α-1 adrenergic receptors. The metabolism of venlafaxine is reported to occur by cytochrome P450 (CYP) enzyme CYP2D6 yielding O-desmethylvenlafaxine. A lesser metabolite, N-desmethylvenlafaxine is produced by CYP3A4. |
| 纯度 | ≥95% |
| pKa值 | pKₐ: 9.27 (Predicted) |
|---|---|
| IC50 | ST: IC₅₀= 30 nM (human); SLC6A2: IC₅₀= 61 nM (human); DATSlc6a3: IC₅₀= 19.6 μM (human) |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 1-[(1R)-2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol |
| INCHI | 1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3/t16-/m0/s1 |
| InChi Key | PNVNVHUZROJLTJ-INIZCTEOSA-N |
| Smiles | CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O |
| Isomeric SMILES | CN(C)C[C@@H](C1=CC=C(C=C1)OC)C2(CCCCC2)O |
| 分子量 | 277.4 |
| Reaxy-Rn | 4234848 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=4234848&ln= |
| 溶解性 | Soluble in ethanol, methanol, and DMSO. |
|---|---|
| 密度 | ~1.1 g/cm3(Predicted) |
| 折光率 | n20D1.54 (Predicted) |
| 比旋光度 | α20D-30.4, c = 0.25 in ethanol |
| 沸点 | ~397.6° C at 760 mmHg (Predicted) |
| 熔点 | 100-102° C |
| 分子量 | 277.400 g/mol |
| XLogP3 | 2.900 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 3 |
| 可旋转键计数Rotatable Bond Count | 5 |
| 精确质量Exact Mass | 277.204 Da |
| 单同位素质量Monoisotopic Mass | 277.204 Da |
| 拓扑极表面积Topological Polar Surface Area | 32.700 Ų |
| 重原子数Heavy Atom Count | 20 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 279.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 信号词 | 警告 |
|---|---|
| 危险声明 |
H319: 引起严重眼睛刺激 |
| 预防措施声明 |
P264: 处理后要彻底洗手。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 |
| RTECS | GV8872620 |